Breast cancer: when tumor markers become targets for drugs.
Ojasoo
T
T
Pierre & Marie Curie University (VI), Paris, France.
Lippman
M E
ME
Rochefort
H
H
Namer
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D010447:Peptide Hydrolases / Q000187:drug effects / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism; D011980:Receptors, Progesterone / Q000187:drug effects / Q000378:metabolism
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D006133:Growth Substances; D011956:Receptors, Cell Surface; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D010447:Peptide Hydrolases